Hantavirus Scare Puts Three Covid-Era Stocks Back in Focus

robot
Abstract generation in progress

The hantavirus outbreak on the MV Hondius briefly revived the pandemic-prep trade in medical stocks and put Moderna, Emergent BioSolutions, and BioNTech back in focus. Moderna rallied 36.08% from $43.69 on May 1 to $59.45 on May 11, while Emergent and BioNTech were highlighted as technical setups to watch in May 2026.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin